Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DV281 |
Trade Name | |
Synonyms | DV-281|DV 281 |
Drug Descriptions |
DV281 is a TLR9 agonist, which may stimulate cytotoxic T-lymphocytes to enhance the immune anti-tumor response (PMID: 30502651). |
DrugClasses | TLR9 Agonist 9 |
CAS Registry Number | NA |
NCIT ID | C143006 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DV281 | DV281 | 0 | 1 |
DV281 + Nivolumab | DV281 Nivolumab | 0 | 0 |